MyFinsight
Home
Blog
About
Contact
Download
Download image
Oncology
$747,585K
Metabolic
$744,957K
Other
$408,548K
Central Nervous System
$254,838K
Cardiology
$239,371K
Antiviral And Anti
Infective
$134,935K
Revenue, net (includes
53.2 million, 50.0...
$2,530,234K
Interest income
(expense), net
$12,780K
Income from operations
$534,935K
Total other income
(expense), net
$7,442K
Total operating
expenses
$1,995,299K
Miscellaneous (expense)
income, net
-$5,338K
Income before income
taxes
$542,377K
Direct operating costs
$1,769,616K
Selling, general and
administrative
$197,559K
Depreciation
$27,178K
Amortization
$946K
Net income
$451,123K
Income tax provision
$91,254K
Reimbursable Out Of Pocket
Costs
$1,037,488K
Direct Costs
$732,128K
Back
Back
Income Statement
source: myfinsight.com
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)